Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Chitogenx Inc. (CHGX.CN)

Chitogenx Inc. (CHGX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 5,122
  • Shares Outstanding, K 78,804
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,230 K
  • 60-Month Beta -0.66
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CHGX.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.06
  • Most Recent Earnings $-0.01 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0400 +62.50%
on 04/05/24
0.0700 -7.14%
on 04/19/24
unch (unch)
since 03/15/24
3-Month
0.0300 +116.67%
on 03/06/24
0.1000 -35.00%
on 01/29/24
-0.0300 (-31.58%)
since 01/26/24
52-Week
0.0300 +116.67%
on 03/06/24
0.1750 -62.86%
on 05/05/23
-0.1100 (-62.86%)
since 04/26/23

Most Recent Stories

More News
CHITOGENX ANNOUNCES EXECUTIVE LEADERSHIP CHANGES

/CNW/ - ChitogenX Inc. (CSE: CHGX) (OTCQB: CHNXF) ("ChitogenX" or the "Company"), a clinical-stage regenerative medicine company, today announced that Philippe...

CHGX.CN : 0.0650 (unch)
CHNXF : 0.0500 (+26.90%)
CHITOGENX REPORTS THIRD QUARTER 2024 RESULTS

Launch of new skin repair development program targeting $19B in unmet medical needs Successful demonstration of protection from joint degeneration and...

CHGX.CN : 0.0650 (unch)
CHNXF : 0.0500 (+26.90%)
CHITOGENX DEMONSTRATES ORTHO-R EFFICACY AND OSTEOARTHRITIS PROTECTION IN LARGE ANIMAL MENISCAL REPAIR STUDY

/CNW/ - ChitogenX Inc. (CSE: CHGX) (OTCQB: CHNXF) ("ChitogenX" or the "Company"), a clinical-stage regenerative medicine company, today announced that ORTHO-R,...

CHGX.CN : 0.0650 (unch)
CHNXF : 0.0500 (+26.90%)
CHITOGENX LAUNCHES BURN AND SKIN REPAIR DEVELOPMENT PROGRAM

/CNW/ - ChitogenX Inc., (CSE: CHGX) (OTCQB: CHNXF) ("ChitogenX" or the "Company"), a clinical-stage regenerative medicine company, today announced that it has...

CHGX.CN : 0.0650 (unch)
CHNXF : 0.0500 (+26.90%)
CHITOGENX REPORTS SECOND QUARTER 2024 RESULTS

/CNW/ - ChitogenX Inc., (CSE: CHGX) (OTCQB: CHNXF) ("ChitogenX" or the "Company"), a clinical-stage regenerative medicine company, today reported its financial...

CHGX.CN : 0.0650 (unch)
CHNXF : 0.0500 (+26.90%)
CHITOGENX RECEIVES NOTICE OF ALLOWANCE FOR KEY PATENT IN UNITED STATES AND CANADA

/CNW/ - ChitogenX Inc., (CSE: CHGX) (OTCQB: CHNXF) ("ChitogenX" or the "Company"), a clinical-stage regenerative medicine company, today announced that it has...

CHGX.CN : 0.0650 (unch)
CHNXF : 0.0500 (+26.90%)
CHITOGENX CONCLUDES ENROLMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL

/CNW/ - ChitogenX Inc., (CSE: CHGX) (OTCQB: CHNXF) ("ChitogenX" or the "Company"), a clinical-stage regenerative medicine company, today announced that it has...

CHGX.CN : 0.0650 (unch)
CHNXF : 0.0500 (+26.90%)
CHITOGENX ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS

/CNW/ - ChitogenX Inc., (CSE: CHGX) (OTCQB: CHNXF) ("ChitogenX" or the "Company"), a clinical-stage regenerative medicine company, today announced the voting...

CHGX.CN : 0.0650 (unch)
CHNXF : 0.0500 (+26.90%)
CHITOGENX REPORTS FIRST QUARTER 2024 RESULTS

Patient recruitment for our Rotator cuff repair Phase I/II trial reached important milestone ORTHO-R soft-tissue residency properties confirmed in...

CHGX.CN : 0.0650 (unch)
CHNXF : 0.0500 (+26.90%)
CHITOGENX RETAINS BRUDER CONSULTING & VENTURE GROUP TO BROADEN AND ACCELERATE ONGOING STRATEGIC DEVELOPMENT PARTNERSHIP DISCUSSIONS

/CNW/ - ChitogenX Inc., (CSE: CHGX) (OTCQB: CHNXF) ("ChitogenX" or the "Company"), a clinical-stage regenerative medicine company, today announced it has...

CHGX.CN : 0.0650 (unch)
CHNXF : 0.0500 (+26.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ChitogenX Inc is a clinical-stage biotech company. It operates in one segment, which is the development of novel therapeutic soft tissue repair technologies.

See More

Key Turning Points

3rd Resistance Point 0.0650
2nd Resistance Point 0.0650
1st Resistance Point 0.0650
Last Price 0.0650
1st Support Level 0.0650
2nd Support Level 0.0650
3rd Support Level 0.0650

See More

52-Week High 0.1750
Fibonacci 61.8% 0.1196
Fibonacci 50% 0.1025
Fibonacci 38.2% 0.0854
Last Price 0.0650
52-Week Low 0.0300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar